Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tyrosinase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | tyrosinase precursor | Get druggable targets OG5_137498 | All targets in OG5_137498 |
Schistosoma japonicum | ko:K00505 tyrosinase [EC1.14.18.1], putative | Get druggable targets OG5_137498 | All targets in OG5_137498 |
Schistosoma mansoni | tyrosinase precursor | Get druggable targets OG5_137498 | All targets in OG5_137498 |
Schistosoma japonicum | ko:K00505 tyrosinase [EC1.14.18.1], putative | Get druggable targets OG5_137498 | All targets in OG5_137498 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | 0.0117 | 0.2097 | 1 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0525 | 0.2503 |
Loa Loa (eye worm) | tyrosinase 1 | 0.0111 | 0.1984 | 0.9463 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 0.2097 | 1 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.0111 | 0.1984 | 0.9463 |
Brugia malayi | Hypothetical tyrosinase-like protein F21C3.2 in chromosome I | 0.0111 | 0.1984 | 0.9463 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0111 | 0.1984 | 0.9463 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0111 | 0.1984 | 0.9463 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1984 | 0.9463 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.0111 | 0.1984 | 0.9463 |
Onchocerca volvulus | 0.0111 | 0.1984 | 0.5 | |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0525 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0525 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0525 | 0.0525 |
Onchocerca volvulus | 0.0111 | 0.1984 | 0.5 | |
Onchocerca volvulus | 0.0111 | 0.1984 | 0.5 | |
Brugia malayi | Common central domain of tyrosinase family protein | 0.0111 | 0.1984 | 0.9463 |
Brugia malayi | ShTK domain containing protein | 0.0111 | 0.1984 | 0.9463 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.0111 | 0.1984 | 0.9463 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1984 | 0.9463 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0525 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0525 | 0.0525 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 0.2097 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0525 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.0525 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0525 | 1 |
Schistosoma mansoni | tyrosinase precursor | 0.0528 | 1 | 1 |
Onchocerca volvulus | 0.0111 | 0.1984 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cell survival (functional) | = 91.6200000000001 % | Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 1 ppm | ChEMBL. | 15125944 |
Cell survival (functional) | = 94.6600000000001 % | Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 10 ppm | ChEMBL. | 15125944 |
Cell survival (functional) | = 104.36 % | Cytotoxicity of compound against Melan-a cells determined as percent cell survival at 100 ppm | ChEMBL. | 15125944 |
IC50 (binding) | = 0.33 uM | Inhibitory activity against mushroom tyrosinase | ChEMBL. | 15125944 |
IC50 (binding) | = 0.33 uM | Inhibitory activity against mushroom tyrosinase | ChEMBL. | 15125944 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.